Skip to main content

6 Result(s)

within W. Y. Lau Remove this filter Cancer Research Remove this filter

and

  1. Article

    Open Access

    Alpha-1-fucosidase as a prognostic indicator for hepatocellular carcinoma following hepatectomy: a large-scale, long-term study

    Preoperative alpha-L-fucosidase (AFU) has been used as a diagnostic biomarker for hepatocellular carcinoma (HCC), but its role as a prognostic predictor after partial hepatectomy has not been well defined. The st...

    K Wang, W Guo, N Li, J Shi, C Zhang, W Y Lau, M Wu, S Cheng in British Journal of Cancer (2014)

    Download PDF (557 KB) View Article

  2. Article

    Open Access

    A nomogram predicting pulmonary metastasis of hepatocellular carcinoma following partial hepatectomy

    Pulmonary metastasis (PM) following curative hepatectomy for hepatocellular carcinoma (HCC) is indicative of a poor prognosis. This study aimed to develop a nomogram to identify patients at high risks of PM.

    J Li, Y Liu, Z Yan, X Wan, Y **a, K Wang, J Liu, W Y Lau, M Wu… in British Journal of Cancer (2014)

    Download PDF (697 KB) View Article

  3. No Access

    Article

    Cure is Possible with Salvage Surgery following Downstaging of Hepatocellular Carcinoma

    Combined modality non-surgical treatment can effectively downstage unresectable hepatocellular carcinoma in some patients to become resectable. Salvage surgery following tumour-downstaging can be curative in t...

    W.Y. Lau in The Chinese-German Journal of Clinical Oncology (2004)

  4. No Access

    Article

    Failure of the Hong Kong criteria to predict the severity of acute pancreatitis

    The results of the present study demonstrate that the HK criteria do not provide effective prediction of severity.

    D. I. Heath, W. C. S. Meng, J. H. Anderson… in International journal of pancreatology (1997)

  5. No Access

    Article

    Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study

    Eighteen patients with inoperable hepatocellular carcinoma (HCC) were treated with intrahepatic arterial yttrium-90 microspheres. All these patients showed a lung shunting below 15% and a tumour-to-normal rati...

    W-Y Lau, W-T Leung, S Ho, NWY Leung, M Chan, J Lin… in British Journal of Cancer (1994)

  6. No Access

    Article

    Phase II study of high-dose ifosfamide in hepatocellular carcinoma

    A phase II study of high-dose ifosfamide in hepatocellular carcinoma was conducted among 17 Chinese patients. The dose of ifosfamide used was 2.5 g/m2 daily given as a continuous infusion for 5 days. In all, 15 p...

    J. Lin, W. Shiu, W. T. Leung, M. Tao, N. Leung… in Cancer Chemotherapy and Pharmacology (1993)